125 related articles for article (PubMed ID: 32686008)
1. The antitumor antibiotic mithramycin: new advanced approaches in modification and production.
Kormanec J; Novakova R; Csolleiova D; Feckova L; Rezuchova B; Sevcikova B; Homerova D
Appl Microbiol Biotechnol; 2020 Sep; 104(18):7701-7721. PubMed ID: 32686008
[TBL] [Abstract][Full Text] [Related]
2. Increased heterologous production of the antitumoral polyketide mithramycin A by engineered Streptomyces lividans TK24 strains.
Novakova R; Núñez LE; Homerova D; Knirschova R; Feckova L; Rezuchova B; Sevcikova B; Menéndez N; Morís F; Cortés J; Kormanec J
Appl Microbiol Biotechnol; 2018 Jan; 102(2):857-869. PubMed ID: 29196786
[TBL] [Abstract][Full Text] [Related]
3. Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy.
Albertini V; Jain A; Vignati S; Napoli S; Rinaldi A; Kwee I; Nur-e-Alam M; Bergant J; Bertoni F; Carbone GM; Rohr J; Catapano CV
Nucleic Acids Res; 2006; 34(6):1721-34. PubMed ID: 16571899
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of c-src transcription by mithramycin: structure-activity relationships of biosynthetically produced mithramycin analogues using the c-src promoter as target.
Remsing LL; Bahadori HR; Carbone GM; McGuffie EM; Catapano CV; Rohr J
Biochemistry; 2003 Jul; 42(27):8313-24. PubMed ID: 12846580
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Sp1-dependent transcription and antitumor activity of the new aureolic acid analogues mithramycin SDK and SK in human ovarian cancer xenografts.
Previdi S; Malek A; Albertini V; Riva C; Capella C; Broggini M; Carbone GM; Rohr J; Catapano CV
Gynecol Oncol; 2010 Aug; 118(2):182-8. PubMed ID: 20452660
[TBL] [Abstract][Full Text] [Related]
6. Mithramycin 2'-Oximes with Improved Selectivity, Pharmacokinetics, and Ewing Sarcoma Antitumor Efficacy.
Liu Y; Eckenrode JM; Zhang Y; Zhang J; Hayden RC; Kyomuhangi A; Ponomareva LV; Cui Z; Rohr J; Tsodikov OV; Van Lanen SG; Shaaban KA; Leggas M; Thorson JS
J Med Chem; 2020 Nov; 63(22):14067-14086. PubMed ID: 33191745
[TBL] [Abstract][Full Text] [Related]
7. Mithramycin SK, a novel antitumor drug with improved therapeutic index, mithramycin SA, and demycarosyl-mithramycin SK: three new products generated in the mithramycin producer Streptomyces argillaceus through combinatorial biosynthesis.
Remsing LL; González AM; Nur-e-Alam M; Fernández-Lozano MJ; Braña AF; Rix U; Oliveira MA; Méndez C; Salas JA; Rohr J
J Am Chem Soc; 2003 May; 125(19):5745-53. PubMed ID: 12733914
[TBL] [Abstract][Full Text] [Related]
8. Expanding the Chemical Diversity of the Antitumoral Compound Mithramycin by Combinatorial Biosynthesis and Biocatalysis: The Quest for Mithralogs with Improved Therapeutic Window.
Méndez C; González-Sabín J; Morís F; Salas JA
Planta Med; 2015 Oct; 81(15):1326-38. PubMed ID: 26393942
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the activity of Sp transcription factors by mithramycin analogues as a new strategy for treatment of metastatic prostate cancer.
Malek A; Núñez LE; Magistri M; Brambilla L; Jovic S; Carbone GM; Morís F; Catapano CV
PLoS One; 2012; 7(4):e35130. PubMed ID: 22545098
[TBL] [Abstract][Full Text] [Related]
10. Heterologous reconstitution of the biosynthesis pathway for 4-demethyl-premithramycinone, the aglycon of antitumor polyketide mithramycin.
Zabala D; Song L; Dashti Y; Challis GL; Salas JA; Méndez C
Microb Cell Fact; 2020 May; 19(1):111. PubMed ID: 32448325
[TBL] [Abstract][Full Text] [Related]
11. Dimerization and DNA recognition rules of mithramycin and its analogues.
Weidenbach S; Hou C; Chen JM; Tsodikov OV; Rohr J
J Inorg Biochem; 2016 Mar; 156():40-7. PubMed ID: 26760230
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS-FLI1 fusion transcript.
Grohar PJ; Glod J; Peer CJ; Sissung TM; Arnaldez FI; Long L; Figg WD; Whitcomb P; Helman LJ; Widemann BC
Cancer Chemother Pharmacol; 2017 Sep; 80(3):645-652. PubMed ID: 28735378
[TBL] [Abstract][Full Text] [Related]
13. Structures of mithramycin analogues bound to DNA and implications for targeting transcription factor FLI1.
Hou C; Weidenbach S; Cano KE; Wang Z; Mitra P; Ivanov DN; Rohr J; Tsodikov OV
Nucleic Acids Res; 2016 Oct; 44(18):8990-9004. PubMed ID: 27587584
[TBL] [Abstract][Full Text] [Related]
14. Engineering precursor metabolite pools for increasing production of antitumor mithramycins in Streptomyces argillaceus.
Zabala D; Braña AF; Flórez AB; Salas JA; Méndez C
Metab Eng; 2013 Nov; 20():187-97. PubMed ID: 24148183
[TBL] [Abstract][Full Text] [Related]
15. An efficient system for stable markerless integration of large biosynthetic gene clusters into Streptomyces chromosomes.
Csolleiova D; Knirschova R; Rezuchova B; Homerova D; Sevcikova B; Matulova M; Núñez LE; Novakova R; Feckova L; Javorova R; Cortés J; Kormanec J
Appl Microbiol Biotechnol; 2021 Mar; 105(5):2123-2137. PubMed ID: 33564923
[TBL] [Abstract][Full Text] [Related]
16. Mithramycin analogues generated by combinatorial biosynthesis show improved bioactivity.
Baig I; Perez M; Braña AF; Gomathinayagam R; Damodaran C; Salas JA; Méndez C; Rohr J
J Nat Prod; 2008 Feb; 71(2):199-207. PubMed ID: 18197601
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Streptomyces argillaceus genes encoding a polyketide synthase involved in the biosynthesis of the antitumor mithramycin.
Lombó F; Blanco G; Fernández E; Méndez C; Salas JA
Gene; 1996 Jun; 172(1):87-91. PubMed ID: 8654997
[TBL] [Abstract][Full Text] [Related]
18. Development of Mithramycin Analogues with Increased Selectivity toward ETS Transcription Factor Expressing Cancers.
Mitra P; Eckenrode JM; Mandal A; Jha AK; Salem SM; Leggas M; Rohr J
J Med Chem; 2018 Sep; 61(17):8001-8016. PubMed ID: 30114371
[TBL] [Abstract][Full Text] [Related]
19. The aureolic acid family of antitumor compounds: structure, mode of action, biosynthesis, and novel derivatives.
Lombó F; Menéndez N; Salas JA; Méndez C
Appl Microbiol Biotechnol; 2006 Nov; 73(1):1-14. PubMed ID: 17013601
[TBL] [Abstract][Full Text] [Related]
20. Folding of the polyketide chain is not dictated by minimal polyketide synthase in the biosynthesis of mithramycin and anthracycline.
Kantola J; Blanco G; Hautala A; Kunnari T; Hakala J; Mendez C; Ylihonko K; Mäntsälä P; Salas J
Chem Biol; 1997 Oct; 4(10):751-5. PubMed ID: 9375253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
